9.23
price up icon2.33%   0.21
after-market Dopo l'orario di chiusura: 9.19 -0.04 -0.43%
loading
Precedente Chiudi:
$9.02
Aprire:
$8.93
Volume 24 ore:
1.06M
Relative Volume:
1.73
Capitalizzazione di mercato:
$564.21M
Reddito:
-
Utile/perdita netta:
$-27.03M
Rapporto P/E:
-10.99
EPS:
-0.84
Flusso di cassa netto:
$-23.97M
1 W Prestazione:
+3.82%
1M Prestazione:
+63.65%
6M Prestazione:
+380.73%
1 anno Prestazione:
+573.72%
Intervallo 1D:
Value
$8.87
$9.44
Intervallo di 1 settimana:
Value
$7.91
$9.44
Portata 52W:
Value
$1.23
$9.44

Corvus Pharmaceuticals Inc Stock (CRVS) Company Profile

Name
Nome
Corvus Pharmaceuticals Inc
Name
Telefono
(650) 900-4520
Name
Indirizzo
863 MITTEN ROAD, BURLINGAME, CA
Name
Dipendente
28
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
CRVS's Discussions on Twitter

Corvus Pharmaceuticals Inc Stock (CRVS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-08-18 Iniziato Oppenheimer Outperform
2021-12-01 Ripresa Jefferies Buy
2021-05-27 Iniziato Cantor Fitzgerald Overweight
2021-02-10 Downgrade Mizuho Buy → Neutral
2019-09-12 Iniziato Mizuho Buy
2019-05-29 Iniziato ROTH Capital Buy
2017-08-24 Aggiornamento Credit Suisse Underperform → Neutral
2017-05-01 Downgrade Credit Suisse Neutral → Underperform
2016-04-18 Iniziato Credit Suisse Outperform
2016-04-18 Iniziato Guggenheim Buy
Mostra tutto

Corvus Pharmaceuticals Inc Borsa (CRVS) Ultime notizie

pulisher
04:27 AM

Corvus Pharmaceuticals (NASDAQ:CRVS) Reaches New 1-Year HighStill a Buy? - MarketBeat

04:27 AM
pulisher
04:24 AM

Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2024 Financial Results on November 12, 2024 - The Manila Times

04:24 AM
pulisher
Nov 04, 2024

Corvus Pharmaceuticals (NASDAQ:CRVS) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat

Nov 04, 2024
pulisher
Oct 31, 2024

Corvus Pharmaceuticals (NASDAQ:CRVS) Lowered to "Sell" Rating by StockNews.com - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Corvus Pharmaceuticals stock soars to 52-week high of $8.74 By Investing.com - Investing.com Canada

Oct 30, 2024
pulisher
Oct 29, 2024

Corvus Pharmaceuticals stock soars to 52-week high of $8.74 - Investing.com

Oct 29, 2024
pulisher
Oct 28, 2024

Corvus Pharmaceuticals (NASDAQ:CRVS) Hits New 12-Month HighHere's What Happened - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Where are the Opportunities in (CRVS) - Stock Traders Daily

Oct 28, 2024
pulisher
Oct 26, 2024

Insiders Rewarded With US$3.9m Addition To Investment As Corvus Pharmaceuticals Stock Hits US$480m - Simply Wall St

Oct 26, 2024
pulisher
Oct 25, 2024

Corvus Pharmaceuticals (NASDAQ:CRVS) Trading Up 6%Here's Why - MarketBeat

Oct 25, 2024
pulisher
Oct 24, 2024

Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Rating Upgraded by Mizuho - MarketBeat

Oct 24, 2024
pulisher
Oct 23, 2024

Corvus Pharmaceuticals (NASDAQ:CRVS) Lifted to "Hold" at StockNews.com - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Corvus Pharmaceuticals secures new South San Francisco lease - Investing.com

Oct 23, 2024
pulisher
Oct 22, 2024

Corvus Pharmaceuticals (NASDAQ:CRVS) Sets New 52-Week HighShould You Buy? - MarketBeat

Oct 22, 2024
pulisher
Oct 21, 2024

Corvus Pharmaceuticals stock soars to 52-week high of $7.67 By Investing.com - Investing.com Australia

Oct 21, 2024
pulisher
Oct 21, 2024

Corvus Pharmaceuticals stock soars to 52-week high of $7.67 - Investing.com India

Oct 21, 2024
pulisher
Oct 19, 2024

CRVS Hits 52-week High Ahead Of Atopic Dermatitis Trial Results - RTTNews

Oct 19, 2024
pulisher
Oct 17, 2024

Insiders of Corvus Pharmaceuticals Getting Good Value On Their US$1.03m Investment - Yahoo Finance

Oct 17, 2024
pulisher
Oct 16, 2024

Upward Trajectory: Corvus Pharmaceuticals Inc (CRVS) Posts a Slidee, Closing at 6.72 - The Dwinnex

Oct 16, 2024
pulisher
Oct 15, 2024

Short Interest in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Expands By 31.1% - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Was Corvus Pharmaceuticals Inc (CRVS)’s session last reading good? - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Corvus Pharmaceuticals Inc (CRVS) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Taking a Closer Look At Corvus Pharmaceuticals Inc (CRVS) Following Its Recent Trade - Knox Daily

Oct 14, 2024
pulisher
Oct 12, 2024

Corvus Pharmaceuticals stock soars to 52-week high of $6.17 By Investing.com - Investing.com Australia

Oct 12, 2024
pulisher
Oct 11, 2024

Corvus Pharmaceuticals stock soars to 52-week high of $6.17 - Investing.com India

Oct 11, 2024
pulisher
Oct 11, 2024

StockNews.com Lowers Corvus Pharmaceuticals (NASDAQ:CRVS) to Sell - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

Corvus Pharmaceuticals Inc [CRVS] insider makes an insider purchase of 20,000 shares worth 34624.0. - Knox Daily

Oct 10, 2024
pulisher
Oct 07, 2024

Trading (CRVS) With Integrated Risk Controls - Stock Traders Daily

Oct 07, 2024
pulisher
Oct 01, 2024

Point72 Asset Management L.P. Acquires Shares of 5,964,510 Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) - MarketBeat

Oct 01, 2024
pulisher
Sep 28, 2024

Corvus Pharmaceuticals (NASDAQ:CRVS) Downgraded to "Sell" at StockNews.com - MarketBeat

Sep 28, 2024
pulisher
Sep 26, 2024

When the Price of (CRVS) Talks, People Listen - Stock Traders Daily

Sep 26, 2024
pulisher
Sep 24, 2024

Croda International (OTCMKTS:COIHD) Sets New 52-Week Low at $26.75 - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Cormorant Asset Management's Strategic Acquisition in Corbus Pha - GuruFocus.com

Sep 24, 2024
pulisher
Sep 24, 2024

Corcept Therapeutics (NASDAQ:CORT) Sets New 52-Week High at $43.81 - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Cormorant asset management buys $7m in Corbus Pharmaceuticals stock By Investing.com - Investing.com Canada

Sep 24, 2024
pulisher
Sep 24, 2024

Closing Figures Unveiled: Corvus Pharmaceuticals Inc (CRVS) Drop -7.95, Closes at 5.44 - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

A stock that deserves closer examination: Corvus Pharmaceuticals Inc (CRVS) - US Post News

Sep 24, 2024
pulisher
Sep 24, 2024

Are Smart Investors Making the Right Decision? Corbus Pharmaceuticals Holdings Inc (CRBP) - SETE News

Sep 24, 2024
pulisher
Sep 24, 2024

Top investors say Corcept Therapeutics Inc (CORT) ticks everything they need - SETE News

Sep 24, 2024
pulisher
Sep 24, 2024

Samlyn Capital LLC Has $11.14 Million Holdings in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Wall Street Analyst Initiated Core Scientific Inc [CORZ]. What else is Wall St. saying - The DBT News

Sep 24, 2024
pulisher
Sep 24, 2024

Where are the Opportunities in (CRBP) - Stock Traders Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Corcel shares drop as explorer raise funds and ups exposure in Angola - Proactive Investors USA

Sep 24, 2024
pulisher
Sep 23, 2024

Corvus Pharmaceuticals Inc [CRVS] Stock bought by Insider Jones William Benton for $34624.0 - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Integral Health Asset Management LLC Invests $4.53 Million in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Spotlight on Corbus Pharmaceuticals: Analyzing the Surge in Options Activity - Benzinga

Sep 23, 2024
pulisher
Sep 23, 2024

Evergreen Capital Management LLC Purchases 1,441 Shares of Coterra Energy Inc. (NYSE:CTRA) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

How does CRBP’s price to cash per share ratio compare in the market? - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

There is no way Corsair Gaming Inc (CRSR) can keep these numbers up - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Mizuho recommends buying Corbus following its drop post-Novo's obesity data (NASDAQ:CRBP) - Seeking Alpha

Sep 23, 2024
pulisher
Sep 23, 2024

450,000 Shares in Core Scientific, Inc. (NASDAQ:CORZ) Bought by P Schoenfeld Asset Management LP - MarketBeat

Sep 23, 2024

Corvus Pharmaceuticals Inc Azioni (CRVS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):